VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
OCGN
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
OCGNOcugen, Inc.
$0.74$251M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksOCGNCash Flow

Ocugen, Inc. (OCGN) Cash Flow Statement

14Y historyFree accessUpdated daily

Free cash flow was negative in every one of the last ten quarters, averaging roughly -$17.2M in 2026 year-to-date versus -$11.4M in 2024, with cumulative operating outflows of $133.6M partly flattered by $20.4M of non-cash stock-based compensation addbacks.

Income StatementBalance SheetCash FlowRatios

OCGN Cash Flow Statement

Annual statement

OCGN Cash Flow Statement

Ocugen, Inc. (OCGN) cash flow statement — 14-year operating, investing & financing cash flows

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12
Cash from Operations-63.69M-56.96M-42.14M-62.05M-60.08M-47.94M-14.71M-16.89M-15.78M-23.02M-25.74M-30.03M-18.41M-15.28M-12.23M
Operating CF Margin %--1290.82%-1039.26%-1028.06%-2414.75%--34206.35%-------191025%-47046.15%
Operating CF Growth %-83.4%-35.17%32.09%-3.29%-25.32%-225.94%12.93%-7.08%31.46%10.55%14.31%-63.18%-20.44%-24.93%-
Net Income-65.36M-67.85M-54.05M-63.08M-86.8M-58.37M-21.82M-20.24M-8.64M-26.41M-16.21M-32.02M-22.79M-25.71M-16.93M
Depreciation & Amortization1.33M2.39M1.97M704K480K229K102K61K49.62K1.53M1.67M1.61M726K566K638K
Stock-Based Compensation9.19M7.71M7.43M9.22M10.54M6.96M660K884.09K1.63M1.57M1.55M1.23M547K158K14K
Deferred Taxes00000-52K03.19M-17.14M1.54M-14.21M321K60K80K2.43M
Other Non-Cash Items-10.32M1.31M-1.15M4.26M6.51M799K7.56M2.33M11.13M-543K-533K-322K672K8.36M1.57M
Working Capital Changes1.47M-523K3.67M-13.16M9.2M2.49M-1.21M-3.11M-2.81M-706K1.99M-851K2.38M1.27M48K
Change in Receivables000000000000000
Change in Inventory000000000000000
Change in Payables-356K00003.5M-540.85M-1.63B-375K-1.21M-304K-2.63M2.03M804K-228K
Cash from Investing-59.84M-311K-3.38M3.08M-16.97M-1.82M-306.82K-2.36M-1.11M-1.23M-320K-1.95M-3.32M-554K-79K
Capital Expenditures-211K-185K-3.38M-10.48M-4.46M-939K-306.82K-29.45K-2.01M-276K-320K-1.95M-3.32M-604K-79K
CapEx % of Revenue4.42%4.19%83.48%173.56%179.14%-713.55%------7550%303.85%
Acquisitions0000000-2.33M0000000
Investments---------------
Other Investing0-126K00761K-877K0-2730000050K0
Cash from Financing115.52M17.33M64.86M20.88M59.48M120.68M31.61M25.07M25.35M-577K27.05M4.37M71.05M9.85M26.69M
Debt Issued (Net)-1.02M-1M30M500K500K-10K-4.73M1.38M-178K-583K-583K-406K1.75M06.01M
Equity Issued (Net)24.35M18.33M38.56M20.45M59.57M129.21M37.82M23.68M25.53M027.63M4.74M70.76M10.26M20.68M
Dividends Paid000000000000000
Share Repurchases0000000-48K0000000
Other Financing92.18M0-3.7M-68K-592K-8.53M-1.48M03K6K2K39K-1.46M-407K0
Net Change in Cash-7.93M-39.93M19.36M-38.1M-17.55M70.92M16.6M5.82M8.46M-24.83M993K-27.61M49.33M-5.98M14.38M
Free Cash Flow-63.9M-57.15M-45.53M-72.53M-64.54M-48.88M-15.02M-16.92M-17.79M-23.3M-26.06M-31.98M-21.73M-15.89M-12.31M
FCF Margin %-1337.16%-1295.01%-1122.74%-1201.62%-2593.89%--34919.9%-------198575%-47350%
FCF Growth %-19.38%-25.53%37.23%-12.39%-32.03%-225.53%11.27%4.88%23.64%10.59%18.53%-47.21%-36.76%-29.04%-
FCF per Share-0.19-0.19-0.17-0.30-0.30-0.25-0.13-1.22-28.78-61.66-108.65-145.03-849.73-74.72-57.90
FCF Conversion (FCF/Net Income)0.98x0.84x0.78x0.98x0.69x0.82x0.67x0.83x1.83x0.87x1.59x0.94x0.81x0.59x0.72x
Interest Paid000000001K30K66K94K18K00
Taxes Paid00000000105K197K257K79K2K00

Key Metrics

Growth RegimeMixed
ProfitabilityWeak
Balance SheetAdequate
Cash FlowMixed
Top Statement Risk

Persistent operating cash burn

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Non-Cash Charges Flatter Cash Burn

Across ten quarters, Ocugen's cumulative net losses of $166.0M exceed its cumulative operating cash outflow of $133.6M, an OCF/NI ratio swinging between 0.50 and 1.26, suggesting a material share of reported losses is non-cash rather than cash-consuming, according to SEC filings.

The gap is most visible in 2026Q2, where the net loss widened to -$24.9M while operating outflow narrowed to -$12.6M on a $6.3M working-capital release and $1.8M of stock-based compensation, implying the deeper headline loss was driven by below-the-line items rather than cash operations. The reverse occurred in 2026Q1, when the 1.14 ratio accompanied a -$6.6M working-capital swing, so conversion quality appears episodic rather than systematically conservative. Since both series are negative, the ratio should be read as a magnitude signal, not evidence of earnings quality in the conventional sense.

Free Cash Burn Widening

Ocugen's free cash flow was negative in all ten quarters, averaging roughly -$11.4M per quarter in 2024, -$14.3M in 2025 and -$17.2M in 2026 year-to-date, a widening trajectory that appears disconnected from its near-flat revenue line, based on Ocugen's reported figures.

Because capex is negligible, the FCF trajectory is effectively an operating-cost trajectory, meaning the worsening burn reflects expense growth rather than investment in future capacity. Reported FCF margins clustered between -7.4% and -14.2% except for 2025Q4, so the burn intensity against revenue has not improved despite five quarters of scale. Investors should monitor whether the 2026Q2 narrowing to -$12.6M persists or proves to be another working-capital-driven swing, as seen previously in 2024Q4 and 2025Q2.

Asset-Light Burn Skips Reinvestment

CapEx totalled only about $3.65M across ten quarters, falling from $2.4M in 2024Q1 to just $21K in 2026Q2, while cumulative depreciation of $5.5M ran ahead of capital spending, per Ocugen's cash flow disclosures.

The collapse in outlays means the CapEx/Revenue ratios of 44.6% and 45.0% in mid-2024 reflected a small denominator and a one-off spending pattern rather than structural capital intensity; more recent prints below 5% are the better run-rate. Depreciation exceeding capex by roughly $1.9M cumulatively suggests the existing asset base is being consumed faster than it is renewed, which is tolerable only if those assets are not revenue-generating. The implication is that essentially none of the $133.6M operating outflow has converted into productive capacity, concentrating the entire return question on commercial execution.

Liquidity Reserved, No Shareholder Returns

Ocugen returned no capital to shareholders across ten quarters, paying zero dividends and net repurchasing less than $0.5M of stock, while cumulative operating outflows reached $133.6M and no acquisition outlays were disclosed, per the cash flow statement.

Gross repurchases of approximately $390K were almost exactly offset by offsets in the opposite direction in 2024Q1, 2025Q1 and 2025Q1-adjacent periods, netting to effectively zero and suggesting share issuance activity rather than a deliberate buyback program. With no dividends, no acquisitions and near-zero capex, essentially all capital activity is being conserved to fund the operating burn, a posture that appears rational for a pre-commercial issuer but leaves no visible return on deployed capital to underwrite. Any change in this pattern, particularly a resumption of buybacks while losses deepen, would warrant a closer look at capital discipline.

Cumulative Gap Tracks Non-Cash Addbacks

Over the ten-quarter window Ocugen accumulated -$166.0M of net income against -$133.6M of operating cash flow, a $32.4M divergence that roughly matches the $20.4M of stock-based compensation and $5.5M of depreciation added back, as derived from the statement of cash flows.

The arithmetic suggests the divergence is explained predominantly by non-cash addbacks rather than by aggressive revenue recognition, which is the more common driver of a positive earnings-to-cash gap. However, the interpretation cuts both ways: $20.4M of stock-based compensation represents real economic cost delivered through dilution, so the cash shortfall understates the true cost of the loss period even though it does not drain the bank account. Investors should therefore treat the cumulative $133.6M outflow as the floor of value destruction, with dilution representing an additional, separately measured drag.

Addbacks and Margin Anomalies Warrant Scrutiny

Cumulative stock-based compensation of $20.4M is added back to operating cash flow without cash leaving the entity, an adjustment equal to roughly 15% of the $133.6M cumulative outflow that also dilutes shareholders, while a reported +72.5% FCF margin in 2025Q4 alongside -$14.0M of free cash flow appears internally inconsistent.

The 2025Q4 margin print is directionally impossible given negative FCF and should be verified against the underlying revenue figure before any margin trend is charted, since a similar distortion would invalidate the -7% to -14% range cited elsewhere. Beyond that, the cash flow statement provides no financing activities in the supplied series, so the runway funding the burn cannot be assessed from these data alone, and the classification of the small capex line as maintenance versus growth is immaterial at this scale but leaves no visibility into capitalized development costs. A short-seller would also note that quarter-to-quarter working-capital swings of +/- $6M, in a business with roughly $1.5M of quarterly revenue, are large relative to the top line and suggest collection or accrual timing that merits scrutiny.

OCGN — Frequently Asked Questions

Quick answers to the most common questions about buying OCGN stock.

How much cash does Ocugen, Inc. (OCGN) generate from operations?

Ocugen, Inc. (OCGN) generated $-57.0M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is Ocugen, Inc.'s free cash flow?

Ocugen, Inc. (OCGN) reported negative free cash flow of $57.1M in 2025, indicating capital requirements exceeded cash from operations.

What is Ocugen, Inc.'s capital expenditure (CapEx)?

Ocugen, Inc. (OCGN) spent $0.2M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.